Table 1.
Demographic Characteristics of fatal Patients With COVID-19.
| Characteristics | n = 20, n (%) |
|---|---|
| Median (IQR) age, years | 66 (60.75–77) |
| <40 years | 1 (5) |
| 40–60 years | 3 (15) |
| ≥60 years | 16 (80) |
| Sex | |
| Female | 6 (30) |
| Male | 14 (70) |
| Huanan Seafood Market exposure | 1 (5) |
| Initial common symptoms | |
| Fever | 15 (75) |
| Cough | 15 (75) |
| dyspnea | 10 (50) |
| Chest pain | 1 (5) |
| Headache | 1 (5) |
| Vomiting | 1 (5) |
| Diarrhoea | 4 (20) |
| Fatigue or myalgia | 10 (50) |
| Chest imaging, infiltratea | |
| Unilateral | 0 (0) |
| Bilateral | 20 (100) |
| Comorbidities | |
| Hypertension | 9 (45) |
| Diabetes | 2 (10) |
| Cardiovascular disease | 10 (50) |
| Chronic lung diseases | 1 (5) |
| Chronic kidney disease | 2 (10) |
| Malignancy | 7 (35) |
| Median (IQR) time from onset of symptom to hospital admission, days | 10 (6.75–14) |
| Median (IQR) time from hospital admission to death, days | 23 (20–30) |
| Vital signs on admission | |
| Disorders of consciousness | 0 (0) |
| Median (IQR) arterial pressure, mm Hg | 137 (120–150) |
| Median (IQR) heart rate, beat per minute | 91 (79–103) |
| Median (IQR) respiratory rate, breaths per minute | 25 (20–30) |
| Median (IQR) percutaneous oxygen saturation, | 92% (86.8%−97.3%) |
| Complications | |
| Sepsis | 18 (90) |
| Respiratory failure | 20 (100) |
| Acute respiratory distress syndrome | 14 (70) |
| Liver dysfunction | 17 (85) |
| Acute kidney injury | 14 (70) |
| Acute cardiac injury | 12 (60) |
| Treatment | |
| Antibacterial therapy | 20 (100) |
| Antiviral therapy | 20 (100) |
| Antifungal therapy | 12 (60) |
| Glucocorticoids therapy | 18 (90) |
| Intravenous immunoglobulin therapy | 11 (55) |
| Interferon inhalation | 3 (15) |
| Oxygen treatment | |
| High flow nasal cannula | 1 (5) |
| Noninvasive ventilation | 3 (15) |
| Invasive mechanical ventilation | 16 (80) |
| Continuous renal replacement therapy | 5 (25) |
| Extracorporeal membrane oxygenation | 0 (0) |